{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:30:22Z","timestamp":1778200222694,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016990","name":"Hellenic Society of Cardiology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016990","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.diabres.2021.108724","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T04:27:27Z","timestamp":1614400047000},"page":"108724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Atrial fibrillation risk in patients suffering from type I diabetes mellitus. A review of clinical and experimental evidence"],"prefix":"10.1016","volume":"174","author":[{"given":"Dimitrios A.","family":"Vrachatis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos A.","family":"Papathanasiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charalampos","family":"Kossyvakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sotiria G.","family":"Giotaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Raisakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos E.","family":"Iliodromitis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Reimers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio G.","family":"Stefanini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Cleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Sianos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Lansky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spyridon G.","family":"Deftereos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Giannopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2021.108724_b0005","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrcardio.2014.118","article-title":"Global epidemiology of atrial fibrillation","volume":"11","author":"Rahman","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.diabres.2021.108724_b0010","article-title":"Temporal trends in incidence, prevalence, and mortality of atrial fibrillation in primary care","author":"Lane","year":"20176","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.diabres.2021.108724_b0015","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.diabres.2021.108724_b0020","article-title":"ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)","volume":"2020","author":"Hindricks","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diabres.2021.108724_b0025","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/CIRCRESAHA.114.303211","article-title":"The clinical profile and pathophysiology of atrial fibrillation: Relationships among clinical features, epidemiology, and mechanisms","volume":"114","author":"Andrade","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.diabres.2021.108724_b0030","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.hlc.2017.05.119","article-title":"Pathophysiology of Paroxysmal and Persistent Atrial Fibrillation: Rotors","volume":"26","author":"Lau","year":"2017","journal-title":"Foci Fibrosis Hear Lung Circ"},{"key":"10.1016\/j.diabres.2021.108724_b0035","doi-asserted-by":"crossref","first-page":"7990","DOI":"10.1073\/pnas.1914853117","article-title":"Loss of insulin signaling may contribute to atrial fibrillation and atrial electrical remodeling in type 1 diabetes","volume":"117","author":"Polina","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.diabres.2021.108724_b0040","doi-asserted-by":"crossref","first-page":"24","DOI":"10.32607\/20758251-2018-10-1-24-33","article-title":"Pathogenesis of type 1 diabetes mellitus and rodent experimental models","volume":"10","author":"Gvazava","year":"2018","journal-title":"Acta Naturae"},{"key":"10.1016\/j.diabres.2021.108724_b0045","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.3892\/mmr.2020.11291","article-title":"Exogenous hydrogen sulfide reduces atrial remodeling and atrial fibrillation induced by diabetes mellitus via activation of the PI3K\/Akt\/eNOS pathway","volume":"22","author":"Xue","year":"2020","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.diabres.2021.108724_b0050","article-title":"Electrical Conduction System Remodeling in Streptozotocin-Induced Diabetes Mellitus Rat Heart","author":"Zhang","year":"201910","journal-title":"Front Physiol"},{"key":"10.1016\/j.diabres.2021.108724_b0055","doi-asserted-by":"crossref","first-page":"7016","DOI":"10.1074\/jbc.M114.607952","article-title":"Down-regulation of the small conductance calcium-activated potassium channels in diabetic mouse atria","volume":"290","author":"Yi","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.diabres.2021.108724_b0060","article-title":"Insulin Treatment Reduces Susceptibility to Atrial Fibrillation in Type 1 Diabetic Mice","author":"Maria","year":"20207","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.diabres.2021.108724_b0065","doi-asserted-by":"crossref","unstructured":"[13] Maria Z, Campolo AR, Lacombe VA. Diabetes alters the expression and translocation of the insulin-sensitive glucose transporters 4 and 8 in the atria. PLoS One 2015;10. https:\/\/doi.org\/10.1371\/journal.pone.0146033.","DOI":"10.1371\/journal.pone.0146033"},{"key":"10.1016\/j.diabres.2021.108724_b0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/cvr\/cvu176","article-title":"Glucose fluctuations increase the incidence of atrial fibrillation in diabetic rats","volume":"104","author":"Saito","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.diabres.2021.108724_b0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.amjcard.2011.03.004","article-title":"Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation","volume":"108","author":"Huxley","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.diabres.2021.108724_b0080","article-title":"A machine learning aided systematic review and meta-analysis of the relative risk of atrial fibrillation in patients with diabetes mellitus","author":"Xiong","year":"20189","journal-title":"Front Physiol"},{"key":"10.1016\/j.diabres.2021.108724_b0085","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s00125-019-4836-y","article-title":"No evidence of a causal association of type 2 diabetes and glucose metabolism with atrial fibrillation","volume":"62","author":"Harati","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2021.108724_b0090","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1161\/CIRCULATIONAHA.116.024921","article-title":"Genetic Obesity and the Risk of Atrial Fibrillation: Causal Estimates from Mendelian Randomization","volume":"135","author":"Chatterjee","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2021.108724_b0095","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/dom.13512","article-title":"Atrial fibrillation and type 2 diabetes: Prevalence, etiology, pathophysiology and effect of anti-diabetic therapies Diabetes","volume":"21","author":"Bell","year":"2019","journal-title":"Obes Metab"},{"key":"10.1016\/j.diabres.2021.108724_b0100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/postgradmedj-2015-133281","article-title":"Pathophysiology of type 1 and type 2 diabetes mellitus: A 90-year perspective","volume":"92","author":"Zaccardi","year":"2016","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.diabres.2021.108724_b0105","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2337\/db16-0806","article-title":"Differentiation of diabetes by pathophysiology, natural history, and prognosis","volume":"66","author":"Skyler","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2021.108724_b0110","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S2213-8587(17)30262-0","article-title":"Risk of atrial fibrillation in people with type 1 diabetes compared with matched controls from the general population: a prospective case-control study","volume":"5","author":"Dahlqvist","year":"2017","journal-title":"Lancet Diabet Endocrinol"},{"key":"10.1016\/j.diabres.2021.108724_b0115","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijcard.2018.03.099","article-title":"Type 1 and type 2 diabetes mellitus and incidence of seven cardiovascular diseases","volume":"262","author":"Larsson","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.diabres.2021.108724_b0120","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijcard.2018.09.016","article-title":"Type 1 diabetes is associated with increased risk of atrial fibrillation","volume":"279","author":"Spartalis","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.diabres.2021.108724_b0125","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(18)31506-X","article-title":"Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study","volume":"392","author":"Rawshani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2021.108724_b0130","article-title":"Risk of early mortality and cardiovascular disease in type 1 diabetes: A comparison with type 2 diabetes, a nationwide study","author":"Bin","year":"201918","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2021.108724_b0135","article-title":"Ethnic and gender differences in the management of type 2 diabetes: A cross-sectional study from Norwegian general practice","author":"Tran","year":"201919","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.diabres.2021.108724_b0140","article-title":"Association of Race and Ethnicity With Glycemic Control and Hemoglobin A1c Levels in Youth With Type 1 Diabetes","author":"Kahkoska","year":"20181","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.diabres.2021.108724_b0145","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.2337\/dc18-2457","article-title":"Risk factors for atrial fibrillation in people with type 1 diabetes: An observational cohort study of 36,258 patients from the Swedish National Diabetes Registry","volume":"42","author":"Hallstr\u00f6m","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2021.108724_b0150","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/1479164117752492","article-title":"Diabetes mellitus and atrial remodelling in patients with paroxysmal atrial fibrillation: Role of electroanatomical mapping and catheter ablation","volume":"15","author":"Grieco","year":"2018","journal-title":"Diabetes Vasc Dis Res"},{"key":"10.1016\/j.diabres.2021.108724_b0155","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijcard.2018.05.037","article-title":"Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: A Danish nationwide cohort study","volume":"268","author":"Fangel","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.diabres.2021.108724_b0160","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jacc.2016.10.069","article-title":"Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation: PREFER in AF","volume":"69","author":"Patti","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabres.2021.108724_b0165","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.amjcard.2019.11.030","article-title":"Endothelial Dysfunction, Fibrinolytic Activity, and Coagulation Activity in Patients With Atrial Fibrillation According to Type II Diabetes Mellitus Status","volume":"125","author":"Patti","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.diabres.2021.108724_b0170","article-title":"Association of antihyperglycemic therapy with risk of atrial fibrillation and stroke in diabetic patients","volume":"55","author":"L\u0103c\u0103tu\u015fu","year":"2019","journal-title":"Med"},{"key":"10.1016\/j.diabres.2021.108724_b0175","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jdiacomp.2015.12.018","article-title":"Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications","volume":"30","author":"Domingueti","year":"2016","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.diabres.2021.108724_b0180","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term effect of goal-directed weight management in an atrial fibrillation cohort: A long-term follow-up study (LEGACY)","volume":"65","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabres.2021.108724_b0185","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jacc.2015.06.488","article-title":"Impact of CARDIOrespiratory FITness on Arrhythmia Recurrence in Obese Individuals With Atrial Fibrillation The CARDIO-FIT Study","volume":"66","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabres.2021.108724_b0190","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.jacc.2014.09.028","article-title":"Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: The ARREST-AF cohort study","volume":"64","author":"Pathak","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabres.2021.108724_b0195","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diabres.2021.108724_b0200","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ijcard.2015.03.052","article-title":"Diabetes mellitus and atrial fibrillation: Pathophysiological mechanisms and potential upstream therapies","volume":"184","author":"Goudis","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.diabres.2021.108724_b0205","article-title":"The association between diabetes mellitus and atrial fibrillation: Clinical and mechanistic insights","author":"Bohne","year":"201910","journal-title":"Front Physiol"},{"key":"10.1016\/j.diabres.2021.108724_b0210","doi-asserted-by":"crossref","first-page":"998","DOI":"10.2353\/ajpath.2009.090126","article-title":"Reduced phosphoinositide 3-kinase (p110\u03b1) activation increases the susceptibility to atrial fibrillation","volume":"175","author":"Pretorius","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.diabres.2021.108724_b0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198533","article-title":"Wider perioperative glycemic fluctuations increase risk of postoperative atrial fibrillation and ICU length of stay","volume":"13","author":"Sim","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diabres.2021.108724_b0220","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/14728214.2018.1446941","article-title":"Emerging pharmacotherapies for the treatment of atrial fibrillation","volume":"23","author":"Capucci","year":"2018","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.diabres.2021.108724_b0225","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/FJC.0000000000000293","article-title":"Biological Therapies for Atrial Fibrillation: Ready for Prime Time?","volume":"67","author":"Donahue","year":"2016","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.diabres.2021.108724_b0230","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pharmthera.2016.10.003","article-title":"Atrial fibrillation: Therapeutic potential of atrial K+ channel blockers","volume":"176","author":"Ravens","year":"2017","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.diabres.2021.108724_b0235","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1253\/circj.CJ-17-1058","article-title":"Metabolic considerations in atrial fibrillation - Mechanistic insights and therapeutic opportunities","volume":"81","author":"Harada","year":"2017","journal-title":"Circ J"},{"key":"10.1016\/j.diabres.2021.108724_b0240","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/FJC.0000000000000313","article-title":"Oxidant and Inflammatory Mechanisms and Targeted Therapy in Atrial Fibrillation: An Update","volume":"66","author":"Gutierrez","year":"2015","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.diabres.2021.108724_b0245","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/dom.13512","article-title":"Atrial fibrillation and type 2 diabetes: Prevalence, etiology, pathophysiology and effect of anti-diabetic therapies","volume":"21","author":"Bell","year":"2019","journal-title":"Diabetes, Obes Metab"},{"key":"10.1016\/j.diabres.2021.108724_b0250","article-title":"Effect of antidiabetic drugs on the risk of atrial fibrillation: mechanistic insights from clinical evidence and translational studies","author":"Lee","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.diabres.2021.108724_b0255","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/CIRCULATIONAHA.119.044183","article-title":"Effect of dapagliflozin on atrial fibrillation in patients with type 2 diabetes mellitus: Insights from the DECLARE-TIMI 58 Trial","author":"Zelniker","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2021.108724_b0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2042018819890527","article-title":"A review of sotagliflozin for use in type 1 diabetes","volume":"10","author":"Nuffer","year":"2019","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.diabres.2021.108724_b0265","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2337\/dc15-0078","article-title":"Current state of type 1 diabetes treatment in the U.S.: Updated data from the t1d exchange clinic registry","volume":"38","author":"Miller","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2021.108724_b0270","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/dme.13689","article-title":"Cardiac repolarization and depolarization in people with Type 1 diabetes with normal ejection fraction and without known heart disease: a case-control study","volume":"35","author":"Isaksen","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2021.108724_b0275","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.cobme.2019.01.001","article-title":"Windows into human health through wearables data analytics","volume":"9","author":"Witt","year":"2019","journal-title":"Curr Opin Biomed Eng"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822721000772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822721000772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:14:51Z","timestamp":1759173291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822721000772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":55,"alternative-id":["S0168822721000772"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2021.108724","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atrial fibrillation risk in patients suffering from type I diabetes mellitus. A review of clinical and experimental evidence","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2021.108724","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108724"}}